Business Context and Reporting Period
This Form 8-K is filed by Platform Specialty Products Corporation (referred to as Element Solutions Inc. post-transaction) for the reporting period ending January 28, 2019. The filing primarily addresses the imminent closing of the sale of the company's Agricultural Solutions business segment (Arysta LifeScience Inc.) to UPL Corporation Ltd. and associated corporate restructuring.
Key Financial Metrics and Agreements
- Debt Hedging: Entered into cross-currency swap transactions on January 24 and 25, 2019, to convert $750 million in U.S. dollar-denominated term loans into fixed-rate euro-denominated debt.
- Swap Terms: Aggregate initial notional amount of €662 million in exchange for $750 million; maturity date is March 31, 2024.
- Financial Results: The company issued a press release on January 28, 2019, containing preliminary unaudited financial results for the three and twelve months ended December 31, 2018. Specific revenue, profit, or cash flow figures are not detailed in this filing text.
Material Changes and Transactions
- Arysta Sale Amendment: Executed Amendment Number One to the Stock Purchase Agreement to facilitate the assignment of acquisition rights to a U.S. subsidiary (US Purchaser) and effect the transaction via a merger structure.
- Leadership Transition: Approved the retirement of CEO Rakesh Sachdev and the appointment of Benjamin Gliklich as CEO, effective upon the closing of the Arysta sale (expected January 31, 2019).
- Board Changes: Benjamin Gliklich was elected to the Board; Martin E. Franklin was named Executive Chairman; Scot R. Benson was appointed President and COO.
- Corporate Name: The company anticipates changing its name to Element Solutions Inc. following the closing of the Arysta sale.
Guidance, Outlook, and Risks
Management announced 2019 financial guidance for Element Solutions Inc. in the accompanying press release (Exhibit 99.1), though specific guidance numbers are not provided in this filing text. The primary contingency is the successful closing of the Arysta sale, which is expected on January 31, 2019. The filing notes that the information regarding financial results and guidance is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the specific 2019 financial guidance figures and preliminary 2018 results in the press release attached as Exhibit 99.1.
- Confirm the final closing date of the Arysta sale, currently expected to be January 31, 2019.
- Review the full text of Amendment Number One to the Stock Purchase Agreement (Exhibit 2.2) for detailed transaction mechanics.
- Monitor the impact of the cross-currency swaps on future interest expense and currency exposure.